Kristina M. Knapp

699 total citations
13 papers, 158 citations indexed

About

Kristina M. Knapp is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Kristina M. Knapp has authored 13 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Kristina M. Knapp's work include Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Kristina M. Knapp is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Kristina M. Knapp collaborates with scholars based in United States and Saudi Arabia. Kristina M. Knapp's co-authors include Ross L. Levine, Jacob L. Glass, Cem Meydan, Andrew M. Intlekofer, Francine E. Garrett-Bakelman, Alan H. Shih, Eytan M. Stein, Katharine Yen, Christopher E. Mason and Kaitlyn Shank and has published in prestigious journals such as Blood, British Journal of Haematology and Cancer Discovery.

In The Last Decade

Kristina M. Knapp

12 papers receiving 156 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristina M. Knapp United States	6	84	73	48	33	22	13	158
Maria López‐Pavía Spain	9	102 1.2×	108 1.5×	31 0.6×	35 1.1×	11 0.5×	21	183
K R Reynolds United States	5	66 0.8×	104 1.4×	72 1.5×	14 0.4×	17 0.8×	10	190
C-M Wendtner Germany	5	64 0.8×	23 0.3×	84 1.8×	27 0.8×	57 2.6×	5	148
Javier Oesterheld United States	8	105 1.3×	67 0.9×	22 0.5×	24 0.7×	21 1.0×	18	217
Kyriaki Manousou Greece	9	85 1.0×	47 0.6×	26 0.5×	15 0.5×	8 0.4×	31	153
Sébastien Lachot France	5	53 0.6×	87 1.2×	33 0.7×	26 0.8×	12 0.5×	12	169
José Antonio Queizán Spain	7	74 0.9×	103 1.4×	48 1.0×	9 0.3×	26 1.2×	13	169
Shanti Amé France	8	32 0.4×	168 2.3×	115 2.4×	21 0.6×	21 1.0×	17	207
Hans‐Günter Derigs Germany	5	61 0.7×	106 1.5×	31 0.6×	29 0.9×	11 0.5×	8	164
Ángela Rodríguez-Trillo Spain	8	52 0.6×	91 1.2×	22 0.5×	14 0.4×	5 0.2×	13	176

Countries citing papers authored by Kristina M. Knapp

Since Specialization

Citations

This map shows the geographic impact of Kristina M. Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina M. Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina M. Knapp more than expected).

Fields of papers citing papers by Kristina M. Knapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina M. Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina M. Knapp. The network helps show where Kristina M. Knapp may publish in the future.

Co-authorship network of co-authors of Kristina M. Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina M. Knapp. A scholar is included among the top collaborators of Kristina M. Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina M. Knapp. Kristina M. Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Weiner, Michael, Annaswamy Raji, Susan Ofner, et al.. (2020). A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution. Current Medical Research and Opinion. 36(4). 583–593. 8 indexed citations

Schleyer, Titus, Siu Hui, Jane Wang, et al.. (2019). Quantifying Unmet Need in Statin-Treated Hyperlipidemia Patients and the Potential Benefit of Further LDL-C Reduction Through an EHR-Based Retrospective Cohort Study. Journal of Managed Care & Specialty Pharmacy. 25(5). 544–554. 15 indexed citations

Shih, Alan H., Cem Meydan, Kaitlyn Shank, et al.. (2017). Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia. Cancer Discovery. 7(5). 494–505. 71 indexed citations

Brown, Fiona C., Paolo Cifani, Esther Drill, et al.. (2016). Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. British Journal of Haematology. 176(1). 86–91. 21 indexed citations

Getta, Bartlomiej, Emily C. Zabor, Sean M. Devlin, et al.. (2016). RAS Pathway Mutations Are Associated with Proliferative Features and Frequently Co-Occur with TET2 mutationsin Philadelphia Negative MPN Subtypes. Blood. 128(22). 4269–4269. 2 indexed citations

Argyropoulos, Kimon V., Robert Vogel, Carly G.K. Ziegler, et al.. (2016). Clonal B cells in Waldenström’s macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling. Leukemia. 30(5). 1116–1125. 25 indexed citations

Lendvai, Nikoletta, Sean M. Devlin, Minal Patel, et al.. (2015). Biomarkers of Cardiotoxicity Among Multiple Myeloma Patients Subsequently Treated with Proteasome Inhibitor Therapy. Blood. 126(23). 4257–4257. 7 indexed citations

Coombs, Catherine C., Sean M. Devlin, Abhinita Mohanty, et al.. (2015). Response to Hypomethylating Agent Therapy in Acute Myeloid Leukemia Based upon Mutations in the DNA Methylation Pathway. Blood. 126(23). 2522–2522. 1 indexed citations

Krivtsov, Andrei V., Xujun Wang, Noushin Farnoud, et al.. (2014). Patient Derived Xenograft (PDX) Models Recapitulate the Genomic-Driver Composition of Acute Leukemia Samples. Blood. 124(21). 286–286. 3 indexed citations

10.

Rampal, Raajit K., Sean M. Devlin, Jay P. Patel, et al.. (2013). Integrated Genetic Profiling Of JAK2 Wildtype Chronic-Phase Myeloproliferative Neoplasms. Blood. 122(21). 1588–1588.

11.

Krivtsov, Andrei V., Xujun Wang, Noushin Farnoud, et al.. (2013). Patient Derived Xenograft (PDX) Models Faithfully Recapitulate The Genetic Composition Of Primary AML. Blood. 122(21). 1328–1328. 1 indexed citations

12.

Gardner, Jeffrey R., Sean M. Devlin, Kristina M. Knapp, et al.. (2012). Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia.. Blood. 120(21). 2482–2482. 2 indexed citations

13.

Gardner, Jeffrey R., Omar Abdel‐Wahab, Mark G. Frattini, et al.. (2010). High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History. Blood. 116(21). 1992–1992. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact